Designing Growth Strategies is in our DNA

Vaccines Market Size, Share & Industry Analysis, By Type (Live Attenuated, Inactivated, Recombinant, mRNA Vaccine, Viral Vectors Vaccines, Toxoid), By Route of Administration (Parenteral & Oral), By Disease Indication (Viral Diseases {Hepatitis A, Hepatitis B, Polio, RSV, Influenza, HPV, Measles/Mumps/Rubella, Rotavirus, Shingles (Herpes Zoster)} & Bacterial Diseases {Pneumococcal Disease, Diphtheria, Meningococcal Disease}), By Age Group (Pediatric & Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers), & Regional Forecast, 2026-2034

Last Updated :June 24, 2026 | Format:PDF | Report ID: 101769

 

Speak to Analyst

man icon
Mail icon
Captcha refresh
What's included in this sample
Market segmentation:

Detailed and granular segments, regions and countries covered

Scope of research:

Comprehensive quantitative data and qualitative insights

Report structure:

Representation of data and insights in the report

Key findings:

Market Estimates, Growth Rate, Largest Region and Segment

Index:

Overview of data and insights in each chapter

Research Methodology:

Summary of research processes adopted

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
  • 2021-2034
  • 2025
  • 2021-2024
  • 238